We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where ...

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

The deal follows a $1.06 billion U.S. contract in July 2024 and a $1.24 billion agreement with an Asia-based pharma a few ...

DORADO, PUERTO RICO - Pharma-Bio Serv, Inc. (OTCQB:PBSV), a consulting firm specializing in regulatory compliance and quality management for various industries, has declared a special dividend for its ...

Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek ...

BridgeBio Pharma Inc (BBIO) stock saw a decline, ending the day at $36.31 which represents a decrease of $-0.36 or -0.98% from the prior close of $36.67. The stock opened at $36.71 and touched a low ...

Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.

AB2 Bio has made an option and licensing agreement with Nippon Shinyaku, granting the latter the option to commercialise ...

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops ...

DORADO, PUERTO RICO / ACCESS Newswire / January 29, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and te ...